Company intelligence / Profile preview

Cohen and Associates

Sarasota-Bradenton area, Florida, United States

Ownership: Private
Development stage: Other

Overview

Cohen and Associates is an established interventional psychiatry clinic providing treatments for suicidal depression, PTSD, and other CNS disorders using ketamine infusions, Spravato, and TMS. Recently, NRx Pharmaceuticals acquired a 49% stake, aiming to create direct patient care channels and provide a foundational clinic model in Florida, leveraging real-world data for future pharmaceutical programs.

Therapeutic areas: NeurologyPsychiatry
Modalities: Small molecule (ketamine)Biologic (Spravato, which is esketamine nasal spray)Device (Transcranial Magnetic Stimulation, TMS)
Industry: Non-Academic Healthcare

Partnerships

NRx Pharmaceuticals (parent/partner via acquisition)

Beyond the preview

Go deeper on Cohen and Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cohen and Associates.

Explore the full profile